Evidence map›Paper›PMID 27389581›Full record

ArticlePloS one2016

PrPC Undergoes Basal to Apical Transcytosis in Polarized Epithelial MDCK Cells.

Alexander Arkhipenko, Sylvie Syan, Guiliana Soraya Victoria, Stéphanie Lebreton, Chiara Zurzolo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander ArkhipenkoUnité de Trafic Membranaire et Pathogénèse, Institut Pasteur, 25-28 rue du docteur Roux, 75015, Paris, France.
Sylvie SyanUnité de Trafic Membranaire et Pathogénèse, Institut Pasteur, 25-28 rue du docteur Roux, 75015, Paris, France.
Guiliana Soraya VictoriaUnité de Trafic Membranaire et Pathogénèse, Institut Pasteur, 25-28 rue du docteur Roux, 75015, Paris, France.
Stéphanie LebretonUnité de Trafic Membranaire et Pathogénèse, Institut Pasteur, 25-28 rue du docteur Roux, 75015, Paris, France.
Chiara ZurzoloUnité de Trafic Membranaire et Pathogénèse, Institut Pasteur, 25-28 rue du docteur Roux, 75015, Paris, France.
Institut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Prion Protein (PrP) is an ubiquitously expressed glycosylated membrane protein attached to the external leaflet of the plasma membrane via a glycosylphosphatidylinositol anchor (GPI). While the misfolded PrPSc scrapie isoform is the infectious agent of prion disease, the cellular isoform (PrPC) is an enigmatic protein with unclear function. Of interest, PrP localization in polarized MDCK cells is controversial and its mechanism of trafficking is not clear. Here we investigated PrP traffic in MDCK cells polarized on filters and in three-dimensional MDCK cysts, a more physiological model of polarized epithelia. We found that, unlike other GPI-anchored proteins (GPI-APs), PrP undergoes basolateral-to-apical transcytosis in fully polarized MDCK cells. Following this event full-length PrP and its cleavage fragments are segregated in different domains of the plasma membrane in polarized cells in both 2D and 3D cultures.

Indexed as

TranscytosisAnimalsBiotinylationCell MembraneCell PolarityDogsEpitopesGlycosylphosphatidylinositolsMadin Darby Canine Kidney CellsPrion DiseasesPrionsProtein BindingProtein DomainsProtein TransportPrPC ProteinsScrapieEpitopesGlycosylphosphatidylinositolsPrionsPrPC Proteins

Identifiers

PMID27389581
PMCPMC4936696
OpenAlexW2468669862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.